← back to search

Charles Antoine Arthaud

Inserm · FR
Area of research
Biochemistry · Management of Technology and Innovation
Research interest
Research interests include Blood transfusion and management, Blood donation and transfusion practices, COVID-19 Clinical Research Studies, and SARS-CoV-2 and COVID-19 Research.
h-index
5
citations
189
works
14
NIH funding
primary concept
email

Recent publications

Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
Frontiers in Immunology 2022cited by 143position: middledoi
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
EBioMedicine 2022cited by 8position: middledoi
Effects and Side Effects of Platelet Transfusion
Hämostaseologie 2021cited by 22position: middledoi
Evidence of CD40L/CD40 pathway involvement in experimental transfusion-related acute lung injury
Scientific Reports 2019cited by 33position: middledoi
NF-κB Links TLR2 and PAR1 to Soluble Immunomodulator Factor Secretion in Human Platelets
Frontiers in Immunology 2017cited by 28position: middledoi
Properties of donated red blood cell components from patients with hereditary hemochromatosis
Transfusion 2016cited by 17position: middledoi
Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers
Transfusion 2015cited by 54position: middledoi
LPS stimulation of purified human platelets is partly dependent on plasma soluble CD14 to secrete their main secreted product, soluble-CD40-Ligand
BMC Immunology 2015cited by 53position: middledoi
Role of Siglec-7 in Apoptosis in Human Platelets
PLoS ONE 2014cited by 46position: middledoi
Immune‐reactive soluble <scp>OX</scp>40 ligand, soluble <scp>CD</scp>40 ligand, and interleukin‐27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions
Transfusion 2013cited by 64position: middledoi
Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion
Clinical Immunology 2012cited by 137position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hind Hamzeh‐Cognasse · Inserm10 papers (2012–2022)Olivier Garraud · Université Claude Bernard Lyon 110 papers (2012–2022)Fabrice Cognasse · Georges Friedel Laboratory10 papers (2012–2022)Marie‐Ange Eyraud · Inserm9 papers (2012–2022)Bruno Pozzetto · Université Claude Bernard Lyon 17 papers (2012–2017)Sandrine Laradi · Université Claude Bernard Lyon 14 papers (2015–2021)Pauline Damien · Université Claude Bernard Lyon 14 papers (2012–2017)Kim Nguyen · University of Padua3 papers (2013–2015)Patrick Mismetti · Université Claude Bernard Lyon 12 papers (2021–2022) · 2 papers (2013–2014)Jocelyne Fagan · Université Claude Bernard Lyon 12 papers (2015–2021)Archibald McNicol · University of Manitoba2 papers (2012–2017)Isabelle Anselme‐Bertrand · Université Claude Bernard Lyon 11 papers (2014–2014)Laurent Bertoletti · Centre Georges François Leclerc1 papers (2022–2022)Marc Sebban · Université Claude Bernard Lyon 11 papers (2015–2015)Chaker Aloui · Université Claude Bernard Lyon 11 papers (2015–2015)Fabrice Zéni · Université Claude Bernard Lyon 11 papers (2012–2012)Amélie Prier · Université Claude Bernard Lyon 11 papers (2022–2022)Pierre Tiberghien · Biomarqueurs d’urgence et de réanimation1 papers (2016–2016)Neil Blumberg · University of Rochester Medical Center1 papers (2017–2017)